CHIE MRI delivers institutional-grade venture evaluation intelligence - sector-benchmarked, source-attributed, and designed to help Indian startups build the institutional credibility they need to scale.
Nominate a Ventureof CHIE-evaluated startups report improved fundraise narrative clarity within 60 days
higher due-diligence pass rate for startups with a CHIE report vs. without
sector-specific trusted data sources cross-verified for every report
sectors covered with India-specific regulatory and market benchmarks
Why CHIE MRI
CHIE MRI synthesises 200+ sector-specific government, regulatory, and institutional data sources to benchmark your venture against the market - not just the founder's claims.
Deterministic, weighted, and auditable. Every CHIE score is reproducible, traceable to specific evidence inputs, and explainable to investors, boards, and policy bodies.
Beyond pitch-deck metrics. CHIE evaluates operational depth, team resilience, IP posture, regulatory compliance readiness, and capital efficiency - the factors that predict long-term survival.
RBC has no equity stake in the ventures it evaluates. CHIE opinions are structurally independent - trusted by institutional investors and government bodies alike.
Purpose-built for the Indian startup ecosystem. Regulatory, financial, and market benchmarks are sourced from SEBI, RBI, MCA, DPIIT, MSME Ministry, NSO, and NITI Aayog - not adapted from Western frameworks.
Validated ventures gain referrals to RBC's curated network of institutional investors, strategic partners, and government programmes aligned to their sector and stage.
Partner with RBC
Incubators, VCs, associations, and institutions can nominate ventures for evaluation. Our team will review the submitted details and get back to you.
